References
Bayliss CR, Jacques AM, Leung MC, Ward DG, Redwood CS et al (2013) Myofibrillar Ca2+−sensitivity is uncoupled from troponin I phosphorylation in hypertrophic obstructive cardiomyopathy due to abnormal troponin T. Cardiovasc Res 97:500–508
Bennett PM (2018) Riding the waves of the intercalated disc of the heart. Biophys Rev 10:955–959. https://doi.org/10.1007/s12551-018-0438-z
Bergmann O, Zdunek S, Felker A, Salehpour M, Alkass K et al (2015) Dynamics of cell generation and turnover in the human heart. Cell 161:1566–1575. https://doi.org/10.1016/j.cell.2015.05.026
dos Remedios CG, Lal SP, Li A, McNamara J, Keogh A et al (2017) The Sydney Heart Bank: improving translational research while eliminating or reducing the use of animal models of human heart disease. Biophys Rev 9:431–441. https://doi.org/10.1007/s12551-017-0305-3
dos Remedios CG, Li A, Lal S (2018) Non-sarcomeric causes of Heart failure: a Sydney Heart Bank perspective. Biophys Rev 10(4):949–954. https://doi.org/10.1007/s12551-018-0441-4
Gehmlich L, Ehler E (2018) Non-sarcomeric causes of heart failure. Biophys Rev 10:943–947. https://doi.org/10.1007/s12551-018-0444-1
Huang Z-P, Ding Y, Chen J, Wu G, Kataoka M, Hu Y, Yang J-H, Liu J, Drakos SG, Selzman CH, Kyselovic J, Qu L-H, dos Remedios CG, Pu WT, Wang D-Z (2016) Long non-coding RNAs link extracellular matrix gene expression to ischemic cardiomyopathy. Cardiovasc Res 112:543–554. https://doi.org/10.1093/cvr/cvw201
Jin SC, Homsy J, Zaidi S, Lu Q, Morton S et al (2017) Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands. Nat Genet 49:1593–1601. https://doi.org/10.1038/ng.3970
Klauke B, Gaertner-Rommel A, Schulz U, Kassner A, Zu Knyphausen E et al (2017) High proportion of genetic cases in patients with advanced cardiomyopathy including a novel homozygous Plakophilin 2-gene mutation. PLoS One 12:e0189489. https://doi.org/10.1371/journal.pone.0189489
Kong SW, Hu Y, Ho J, Ikeda S, Polster S, John R, Hall JL, Bisping E, Pieske B, dos Remedios CG, Pu WT (2010) Heart failure associated changes in RNA splicing of sarcomere genes. Circ Cardiovasc Genet 3:138–146
Lal S, Li A, Allen D, Allen PD, Bannon P et al (2015) Best practice BioBanking of human heart tissue. Biophys Rev 7:399–406
Li A, Estigoy C, Raftery M, Cameron D, Odeberg J et al (2013) Heart research advances using database search engines, human protein atlas and the Sydney Heart Bank. Heart Lung Circ 22:819–826. https://doi.org/10.1016/j.hlc.2013.06.006
Lin Z, Guo H, Cao Y, Zohrabian S, Zhou P, Ma Q, VanDusen N, Guo Y, Zhang J, Stevens SM, Liang F, Quan Q, van Gorp PR, Li A, dos Remedios C, He A, Bezzerides VJ, Pu WT (2016) Acetylation of VGLL4 regulates hippo-YAP signaling and postnatal growth. Dev Cell 39:466–479. https://doi.org/10.1016/j.devcel.2016.09.005
Marston S, Montgiraud C, Munster AB, Copeland O, Onjee C et al (2015) OBSCN mutations associated with dilated cardiomyopathy and haploinsufficiency. PLoS One 10:e0138568. https://doi.org/10.1371/journal.pone.0138568
Messer AE, Bayliss CR, El-Mezgueldi M, Redwood CS, Ward DG et al (2016) Mutations in troponin T associated with hypertrophic cardiomyopathy increase Ca2+−sensitivity and suppress the modulation of Ca2+−sensitivity by troponin I phosphorylation. Arch Biochem Biophys 601:113–120. https://doi.org/10.1016/j.abb.2016.03.027
Mollova M, Bersell K, Walsh S, Savla J, Das LT et al (2013) Cardiomyocyte proliferation contributes to heart growth in young humans. Proc Natl Acad Sci U S A 110:1446–1451
Papadaki M, Vivhorev PG, Marston SB, Messer A (2015) Uncoupling of myofilament Ca2+−sensitivity from troponin I phosphorylation by mutations can be reversed by epigallocatechin-3-gallate. Cardiovasc Res 108:99–110. https://doi.org/10.1093/cvr/cvv181
Piroddi N, Witjas-Paalberends ER, Ferrara C, Ferrantini C, Vitale G et al (2019) The homozygous K280N troponin T mutation alters cross-bridge kinetics and energetics in human HCM. J Gen Physiol 151:18–29. https://doi.org/10.1085/jgp.201812160
Polizzotti BD, Ganapathy B, Walsh S, Choudhury S, Ammanamanchi N et al (2015) Stimulation of cardiomyocyte regeneration in neonatal mice and in human myocardium with neuregulin reveals a therapeutic window. Sci Translat Medic 7. https://doi.org/10.1126/scitranslmed.aaa5171
Sequeira V, Wijnker PJM, Nijenkamp LAM, Najafi A, Rosalie Witjas-Paalberends (2013) Perturbed length-dependent activation in human hypertrophic cardiomyopathy with sarcomere mutations in myosin and thin filament proteins. Circ Res 112:1491–1505
Stroud MJ (2018) Linker of nucleoskeleton and cytoskeleton complex proteins in cardiomyopathy. Biophys Rev 10:1033–1051. https://doi.org/10.1007/s1255-1-018-0431-6
Witjas-Paalberends P, Tencate FJ, Michels M, Niessen JWM, Poggesi C et al (2013) Cellular dysfunction in hypertrophic cardiomyopathy. Cardiovasc Res 99:432–441
Witjas-Paalberends ER, Güçlü A, Germans T, Knaapen P, Harms HJ et al (2014) Gene-specific increase in energetic cost of contraction in hypertrophic cardiomyopathy caused by thick filament mutations. Cardiovasc Res 103:248–257
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Amy Li declares that she has no conflict of interest. Sean Lal declares that he has no conflict of interest. Cristobal G. dos Remedios declares that he has no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(DOCX 79 kb)
Rights and permissions
About this article
Cite this article
Li, A., Lal, S. & dos Remedios, C.G. A step towards understanding the molecular nature of human heart failure: advances using the Sydney Heart Bank collection. Biophys Rev 11, 241–244 (2019). https://doi.org/10.1007/s12551-019-00514-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12551-019-00514-5